Sugimoto Maki, Takada Tadahiro, Yasuda Hideki, Nagashima Ikuo, Amano Hodaka, Yoshida Masahiro, Miura Fumihiko, Uchida Toyohiko, Isaka Takahiro, Toyota Naoyuki, Wada Keita, Takagi Kenji, Kato Kenichiro
Department of Surgery, Teikyo University School of Medicine, Ichihara Hospital, Chiba, Japan.
Hepatogastroenterology. 2005 May-Jun;52(63):940-3.
Curative resection does not always equate with long-term survival. Cancer of the papilla Vater can remain clinically quiescent for decades prior to regional or distant recurrence. Nevertheless, late and ultra-late recurrence (respectively 10 and 15 years after initial treatment) are exceptional events. This protracted disease-free interval challenges the concept of a "cure" for cancer of the papilla Vater. In the first case reported here, a 74-year-old female underwent pancreaticoduodenectomy in 1985 for cancer of the papilla Vater revealed histologically as a well-differentiated papillotubular adenocarcinoma, stage IA (UICC classification). Multiple hepatic recurrences were found 17 years after the operation; hepatic biopsy showed histologically well to moderately differentiated papillotubular adenocarcinoma. She died about 17.5 years after the original operation. The second case is that of an 82-year-old female who underwent pancreaticoduodenectomy in 1974 for cancer of the papilla Vater, histologically a well-differentiated adenocarcinoma, stage IA. In the 25.5 years after the operation, the cancer recurred at the choledochoduodenal anastomosis and involved the liver hilus. Autopsy showed histologically well to moderately differentiated adenocarcinoma at the locations indicated, together with lung and lymph node metastases. The ultra-late recurrences (>15 years) in these cases are highly exceptional and, to our knowledge, this is the first report of such recurrences in cancer of the papilla Vater. It can occur in any patient, with or without identifiable risk factors. Because cancer of the papilla Vater can recur in many prognostically favorable cases after prolonged disease-free intervals, the possibility of delayed recurrence should not be ignored.
根治性切除并不总是等同于长期生存。 Vater壶腹癌在局部或远处复发之前可能在临床上保持数十年的静止状态。然而,晚期和超晚期复发(分别在初始治疗后10年和15年)是罕见事件。这种漫长的无病间期对Vater壶腹癌“治愈”的概念提出了挑战。在此报告的首例病例中,一名74岁女性于1985年因Vater壶腹癌接受了胰十二指肠切除术,组织学检查显示为高分化乳头管状腺癌,IA期(UICC分类)。术后17年发现多处肝复发;肝活检组织学显示为高分化至中分化乳头管状腺癌。她在初次手术后约17.5年死亡。第二例是一名82岁女性,1974年因Vater壶腹癌接受了胰十二指肠切除术,组织学为高分化腺癌,IA期。术后25.5年,癌症在胆总管十二指肠吻合处复发并累及肝门。尸检显示在所示部位组织学为高分化至中分化腺癌,同时伴有肺和淋巴结转移。这些病例中的超晚期复发(>15年)极为罕见,据我们所知,这是Vater壶腹癌此类复发的首例报告。它可发生于任何患者,无论有无可识别的危险因素。由于Vater壶腹癌在许多预后良好的病例中在长时间无病间期后仍可复发,延迟复发的可能性不应被忽视。